Company intelligence / Profile preview
Steigerwald Arzneimittelwerk
Darmstadt, Hessen, Germanybayer.com ↗
- Ownership
- Private
- Employees
- ~180
- Development stage
- Other
01
Overview
Steigerwald Arzneimittelwerk specializes in the research, development, and manufacture of high-quality herbal medicines. Its leading products include Iberogast for functional gastrointestinal disorders and Laif for mild to moderate depression. The company invests significantly in clinical and pharmacological studies to demonstrate efficacy and safety. It was acquired by Bayer in 2013 but continues operations as part of Bayer’s Consumer Health division with a focus on phytopharmaceuticals.
- Therapeutic areas
- PsychiatryGastroenterology
- Modalities
- Small moleculeHerbal medicine
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Steigerwald Arzneimittelwerk.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Steigerwald Arzneimittelwerk.